PURPOSE: The primary responsibility of institutional review boards is to protect human research subjects and, therefore, ensure that studies are performed in accordance with a standard set of ethical principles. A number of groups have compared the responses of institutional review boards in multicenter clinical trials involving medical therapies. To our knowledge no such studies have been performed to date of trials investigating surgical intervention. We investigated the consistency of the recommendations issued by various institutional review boards in the Minimally Invasive Surgical Therapies study for benign prostatic hyperplasia, a multicenter trial with a uniform consent and study protocol. MATERIALS AND METHODS: We obtained the institutional review board response from 6 of the 7 participating institutions after initial submission of the Minimally Invasive Surgical Therapies study protocol and classified the responses. We then redistributed the approved protocols to an institutional review board at another participating institution and analyzed that review of these protocols. RESULTS: We found that the number and type of responses required for institutional review board approval of an identical study protocol varied significantly among participating institutions. We also found that institutional review board responses were inconsistent in the second review, although all protocols were ultimately approved. CONCLUSIONS: The current system of local institutional review board review in the context of a multicenter surgical trial is inefficient in the review process and may not provide expertise for overseeing surgical trials. Based on these results a central surgical institutional review board may be needed to improve the ethical review process in multicenter trials.
PURPOSE: The primary responsibility of institutional review boards is to protect human research subjects and, therefore, ensure that studies are performed in accordance with a standard set of ethical principles. A number of groups have compared the responses of institutional review boards in multicenter clinical trials involving medical therapies. To our knowledge no such studies have been performed to date of trials investigating surgical intervention. We investigated the consistency of the recommendations issued by various institutional review boards in the Minimally Invasive Surgical Therapies study for benign prostatic hyperplasia, a multicenter trial with a uniform consent and study protocol. MATERIALS AND METHODS: We obtained the institutional review board response from 6 of the 7 participating institutions after initial submission of the Minimally Invasive Surgical Therapies study protocol and classified the responses. We then redistributed the approved protocols to an institutional review board at another participating institution and analyzed that review of these protocols. RESULTS: We found that the number and type of responses required for institutional review board approval of an identical study protocol varied significantly among participating institutions. We also found that institutional review board responses were inconsistent in the second review, although all protocols were ultimately approved. CONCLUSIONS: The current system of local institutional review board review in the context of a multicenter surgical trial is inefficient in the review process and may not provide expertise for overseeing surgical trials. Based on these results a central surgical institutional review board may be needed to improve the ethical review process in multicenter trials.
Authors: Liselotte N Dyrbye; Matthew R Thomas; Alex J Mechaber; Anne Eacker; William Harper; F Stanford Massie; David V Power; Tait D Shanafelt Journal: Acad Med Date: 2007-07 Impact factor: 6.893
Authors: William D Schlaff; Heping Zhang; Michael P Diamond; Christos Coutifaris; Peter R Casson; Robert G Brzyski; Gregory M Christman; Kurt T Barnhart; J C Trussell; Stephen A Krawetz; Peter J Snyder; Dana Ohl; Nanette Santoro; Esther Eisenberg; Hao Huang; Richard S Legro Journal: Fertil Steril Date: 2011-06-08 Impact factor: 7.329
Authors: P Pearl O'Rourke; Judith Carrithers; Bray Patrick-Lake; Todd W Rice; Jeremy Corsmo; Raffaella Hart; Marc K Drezner; John D Lantos Journal: Clin Trials Date: 2015-09-15 Impact factor: 2.486
Authors: Carol M Ashton; Nelda P Wray; Anna F Jarman; Jacob M Kolman; Danielle M Wenner; Baruch A Brody Journal: J Med Ethics Date: 2011-03-23 Impact factor: 2.903
Authors: Michael P Diamond; Esther Eisenberg; Hao Huang; Christos Coutifaris; Richard S Legro; Karl R Hansen; Anne Z Steiner; Marcelle Cedars; Kurt Barnhart; Tracy Ziolek; Tracey R Thomas; Kate Maurer; Stephen A Krawetz; Robert A Wild; J C Trussell; Nanette Santoro; Heping Zhang Journal: Clin Trials Date: 2018-10-24 Impact factor: 2.486
Authors: Carmen C Polito; Sushma K Cribbs; Greg S Martin; Terence O'Keeffe; Dan Herr; Todd W Rice; Jonathan E Sevransky Journal: Crit Care Med Date: 2014-05 Impact factor: 7.598
Authors: Laura A Petersen; Kate Simpson; Richard Sorelle; Tracy Urech; Supicha Sookanan Chitwood Journal: Ann Intern Med Date: 2012-05-15 Impact factor: 25.391